DGFT Issues New Directive On RCMC For Medical Devices To Avail Benefits Under RODTEP Scheme

Mumbai: The Directorate General of Foreign Trade (DGFT), under the Union ministry of commerce & industry, has issued a directive addressing the issuance of Registration-Cum-Membership Certificate (RCMC) for medical devices. This directive is aimed at resolving the difficulties faced by the medical device industry in obtaining the necessary certifications for export benefits under the Remission of Duties and Taxes on Exported Products (RODTEP) scheme.

The DGFT’s Public Notice No. 18/2023 dated June 23, 2023, included the Export Promotion Council (EPC) for Medical Devices in Appendix 2T of the Foreign Trade Policy (FTP) 2023. This inclusion was meant to authorize the EPC for Medical Devices to issue RCMCs for specific items, with existing RCMCs issued by Engineering Export Promotion Council of India (EEPC India) remaining valid until their expiry.

The EPC for medical devices has not yet begun regular operations or integrated into the DGFT’s Common Digital Platform for issuing RCMCs. This has caused significant delays and complications for the medical device industry in obtaining the mandatory RCMC required for export benefits and customs clearance.

To mitigate these issues, DGFT has decided that until the EPC for medical devices becomes fully operational, RCMCs can be issued by the EEPC India and any other relevant EPC for medical devices. This temporary measure is intended to facilitate smoother operations for the medical device industry.

EEPC India is the trade and investment promotion organization for the engineering sector sponsored by the Union ministry of commerce & industry. Set up in 1955, EEPC India now has a membership base of over 12,000 out of whom 60% are SMEs.

Customs authorities have been requested to accept RCMCs issued by EEPC India and any other concerned EPC for medical devices until further notice. This directive aims to ensure that medical device exports continue without unnecessary hindrances.

This decision, approved by the competent authority, is expected to provide immediate relief to the medical device industry, ensuring continued access to export benefits and smoother customs processes.

This announcement reflects the Union ministry of commerce & industry’s commitment to supporting the medical device sector and addressing the challenges faced by exporters. The interim measures will remain in place until the EPC for medical devices is fully functional, ensuring that the industry’s export activities are not disrupted.

Related Posts

  • Pharma
  • January 24, 2025
  • 8 views
AI Can Develop Personalised MRNA Cancer Vaccine In 48 Hours: Oracle’s Larry Ellison

New Delhi:  Artificial Intelligence (AI) can help develop a customised vaccine against cancer for an individual in just 48 hours, said Oracle chairman Larry Ellison. At the launch of the…

  • Pharma
  • January 24, 2025
  • 14 views
Nearly 10 Million Malaria Vaccine Doses Delivered To Africa After Immunization Roll Out: Gavi Vaccine Alliance

GENEVA:  Nearly 10 million malaria vaccine doses were delivered to Africa during the first year of routine immunisation being rolled out across the continent, the Gavi vaccine alliance said Wednesday.…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

AI Can Develop Personalised MRNA Cancer Vaccine In 48 Hours: Oracle’s Larry Ellison

AI Can Develop Personalised MRNA Cancer Vaccine In 48 Hours: Oracle’s Larry Ellison

Nearly 10 Million Malaria Vaccine Doses Delivered To Africa After Immunization Roll Out: Gavi Vaccine Alliance

Nearly 10 Million Malaria Vaccine Doses Delivered To Africa After Immunization Roll Out: Gavi Vaccine Alliance

5 Thousand Banned Capsules Recovered From A Youth In Arniwala

5 Thousand Banned Capsules Recovered From A Youth In Arniwala

Piramal Pharma surges 4% after launching drug for psychiatric disorders

Piramal Pharma surges 4% after launching drug for psychiatric disorders

India’s pharma sector champions quality, innovation

India’s pharma sector champions quality, innovation

Gujarat pharma market rebounds to double-digit growth in 2024

Gujarat pharma market rebounds to double-digit growth in 2024